Latvia vs Mongolia: Cause of death, by non-communicable diseases, ages 60+, male
Latvia
81.6%
in 2021
Mongolia
82.5%
in 2021
Latvia rank
35th
Mongolia rank
32nd
Cause of death, by non-communicable diseases, ages 60+, male over time
- Latvia
- Mongolia
How they compare
Mongolia currently reports 82.5% against 81.6% in Latvia, a difference of 0.9%.
Across all 6 years both countries report, Mongolia has been ahead every year.
Latvia ranks 35th and Mongolia ranks 32nd of 185 countries.
Mongolia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.8% | 94.2% | 2.3% | Mongolia |
| 2010s | 94.0% | 94.8% | 0.8% | Mongolia |
| 2020s | 86.4% | 88.8% | 2.5% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Latvia or Mongolia?
- Mongolia, at 82.5% against 81.6% in Latvia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Latvia and Mongolia?
- 0.9%, with Mongolia ahead.
- How many years of comparable data are there for Latvia and Mongolia?
- 6 years are reported by both, from 2000 to 2021.
- How do Latvia and Mongolia rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Latvia ranks 35th and Mongolia ranks 32nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.